To evaluate the effect of Celastrol supplementation on AngII-induced AAA formation in hypercholesterolemic mice, we initiated a pilot study utilizing male Ldl receptor -/- mice (8 weeks old; n = 12–13 per group). This evidence concerns the gene LDLR and triple-A syndrome.